Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibrin monomer is a protein fragment produced during the blood coagulation process. It forms when thrombin cleaves fibrinogen, transforming it into insoluble fibrin monomers, which are essential intermediates in clot formation. Measurement of soluble fibrin monomer levels in plasma serves as an early marker for activation of coagulation and ongoing thrombosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibrin Monomer.